Literature DB >> 22128169

Sh3rf2/POSHER protein promotes cell survival by ring-mediated proteasomal degradation of the c-Jun N-terminal kinase scaffold POSH (Plenty of SH3s) protein.

Michael Wilhelm1, Nickolay V Kukekov, Travis L Schmit, Katherine V Biagas, Andrew A Sproul, Stephen Gire, Margaret E Maes, Zhiheng Xu, Lloyd A Greene.   

Abstract

We report that Sh3rf2, a homologue of the pro-apoptotic scaffold POSH (Plenty of SH3s), acts as an anti-apoptotic regulator for the c-Jun N-terminal kinase (JNK) pathway. siRNA-mediated knockdown of Sh3rf2 promotes apoptosis of neuronal PC12 cells, cultured cortical neurons, and C6 glioma cells. This death appears to result from activation of JNK signaling. Loss of Sh3rf2 triggers activation of JNK and its target c-Jun. Also, apoptosis promoted by Sh3rf2 knockdown is inhibited by dominant-negative c-Jun as well as by a JNK inhibitor. Investigation of the mechanism by which Sh3rf2 regulates cell survival implicates POSH, a scaffold required for activation of pro-apoptotic JNK/c-Jun signaling. In cells lacking POSH, Sh3rf2 knockdown is unable to activate JNK. We further find that Sh3rf2 binds POSH to reduce its levels by a mechanism that requires the RING domains of both proteins and that appears to involve proteasomal POSH degradation. Conversely, knockdown of Sh3rf2 promotes the stabilization of POSH protein and activation of JNK signaling. Finally, we show that endogenous Sh3rf2 protein rapidly decreases following several different apoptotic stimuli and that knockdown of Sh3rf2 activates the pro-apoptotic JNK pathway in neuronal cells. These findings support a model in which Sh3rf2 promotes proteasomal degradation of pro-apoptotic POSH in healthy cells and in which apoptotic stimuli lead to rapid loss of Sh3rf2 expression, and consequently to stabilization of POSH and JNK activation and cell death. On the basis of these observations, we propose the alternative name POSHER (POSH-eliminating RING protein) for the Sh3rf2 protein.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22128169      PMCID: PMC3265902          DOI: 10.1074/jbc.M111.269431

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene.

Authors:  D D Yang; C Y Kuan; A J Whitmarsh; M Rincón; T S Zheng; R J Davis; P Rakic; R A Flavell
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

Review 2.  Targeting the JNK signaling pathway for stroke and Parkinson's diseases therapy.

Authors:  Chia-Yi Kuan; Robert E Burke
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2005-02

3.  Regulation of apoptotic c-Jun N-terminal kinase signaling by a stabilization-based feed-forward loop.

Authors:  Zhiheng Xu; Nikolay V Kukekov; Lloyd A Greene
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

4.  Novel function of POSH, a JNK scaffold, as an E3 ubiquitin ligase for the Hrs stability on early endosomes.

Authors:  Gun-Hwa Kim; Eunjoo Park; Young-Yun Kong; Jin-Kwan Han
Journal:  Cell Signal       Date:  2005-08-09       Impact factor: 4.315

5.  Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK.

Authors:  W S Choi; S Y Yoon; T H Oh; E J Choi; K L O'Malley; Y J Oh
Journal:  J Neurosci Res       Date:  1999-07-01       Impact factor: 4.164

6.  JIP1 regulates neuronal apoptosis in response to stress.

Authors:  Zhaohui Dong; Li Zhou; Keith Del Villar; Mahin Ghanevati; Vartan Tashjian; Carol A Miller
Journal:  Brain Res Mol Brain Res       Date:  2005-04-04

7.  The JIP group of mitogen-activated protein kinase scaffold proteins.

Authors:  J Yasuda; A J Whitmarsh; J Cavanagh; M Sharma; R J Davis
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

8.  A cytoplasmic inhibitor of the JNK signal transduction pathway.

Authors:  M Dickens; J S Rogers; J Cavanagh; A Raitano; Z Xia; J R Halpern; M E Greenberg; C L Sawyers; R J Davis
Journal:  Science       Date:  1997-08-01       Impact factor: 47.728

9.  Knock-down of POSH expression is neuroprotective through down-regulating activation of the MLK3-MKK4-JNK pathway following cerebral ischaemia in the rat hippocampal CA1 subfield.

Authors:  Quan-Guang Zhang; Rui-Min Wang; Xiao-Hui Yin; Jing Pan; Tian-Le Xu; Guang-Yi Zhang
Journal:  J Neurochem       Date:  2005-11       Impact factor: 5.372

10.  The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development.

Authors:  C Y Kuan; D D Yang; D R Samanta Roy; R J Davis; P Rakic; R A Flavell
Journal:  Neuron       Date:  1999-04       Impact factor: 17.173

View more
  14 in total

1.  Modulation of p38 kinase by DUSP4 is important in regulating cardiovascular function under oxidative stress.

Authors:  Alma Barajas-Espinosa; Ariel Basye; Mark G Angelos; Chun-An Chen
Journal:  Free Radic Biol Med       Date:  2015-07-14       Impact factor: 7.376

2.  Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies.

Authors:  Daniel Reichart; Eric L Lindberg; Henrike Maatz; Hendrik Milting; Michela Noseda; Gavin Y Oudit; Matthias Heinig; Jonathan G Seidman; Norbert Hubner; Christine E Seidman; Antonio M A Miranda; Anissa Viveiros; Nikolay Shvetsov; Anna Gärtner; Emily R Nadelmann; Michael Lee; Kazumasa Kanemaru; Jorge Ruiz-Orera; Viktoria Strohmenger; Daniel M DeLaughter; Giannino Patone; Hao Zhang; Andrew Woehler; Christoph Lippert; Yuri Kim; Eleonora Adami; Joshua M Gorham; Sam N Barnett; Kemar Brown; Rachel J Buchan; Rasheda A Chowdhury; Chrystalla Constantinou; James Cranley; Leanne E Felkin; Henrik Fox; Ahla Ghauri; Jan Gummert; Masatoshi Kanda; Ruoyan Li; Lukas Mach; Barbara McDonough; Sara Samari; Farnoush Shahriaran; Clarence Yapp; Caroline Stanasiuk; Pantazis I Theotokis; Fabian J Theis; Antoon van den Bogaerdt; Hiroko Wakimoto; James S Ware; Catherine L Worth; Paul J R Barton; Young-Ae Lee; Sarah A Teichmann
Journal:  Science       Date:  2022-08-05       Impact factor: 63.714

Review 3.  Drosophila as a model to explore secondary injury cascades after traumatic brain injury.

Authors:  Lori M Buhlman; Gokul Krishna; T Bucky Jones; Theresa Currier Thomas
Journal:  Biomed Pharmacother       Date:  2021-08-27       Impact factor: 7.419

4.  N-VEGF, the Autoregulatory Arm of VEGF-A.

Authors:  Marina Katsman; Aviva Azriel; Guy Horev; Yitzhak Reizel; Ben-Zion Levi
Journal:  Cells       Date:  2022-04-11       Impact factor: 7.666

Review 5.  Programmed cell death during neuronal development: the sympathetic neuron model.

Authors:  M Kristiansen; J Ham
Journal:  Cell Death Differ       Date:  2014-04-25       Impact factor: 15.828

6.  Functional analysis of SH3 domain containing ring finger 2 during the myogenic differentiation of quail myoblast cells.

Authors:  Si Won Kim; Jeong Hyo Lee; Tae Sub Park
Journal:  Asian-Australas J Anim Sci       Date:  2016-12-27       Impact factor: 2.509

7.  SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation.

Authors:  Peiyuan Zhang; Yingjie Liu; Cheng Lian; Xuan Cao; Yuan Wang; Xiaoxun Li; Min Cong; Pu Tian; Xue Zhang; Gang Wei; Tong Liu; Guohong Hu
Journal:  Nat Commun       Date:  2020-05-19       Impact factor: 14.919

Review 8.  The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer.

Authors:  Manel B Hammouda; Amy E Ford; Yuan Liu; Jennifer Y Zhang
Journal:  Cells       Date:  2020-04-02       Impact factor: 6.600

9.  c-Jun N-terminal kinase regulates mGluR-dependent expression of post-synaptic FMRP target proteins.

Authors:  Travis L Schmit; James A Dowell; Margaret E Maes; Michael Wilhelm
Journal:  J Neurochem       Date:  2013-10-24       Impact factor: 5.372

10.  Molecular characterization of the apoptosis-related SH3RF1 and SH3RF2 genes and their association with exercise performance in Arabian horses.

Authors:  K Ropka-Molik; M Stefaniuk-Szmukier; K Piórkowska; T Szmatoła; M Bugno-Poniewierska
Journal:  BMC Vet Res       Date:  2018-08-14       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.